DCM Shriram Fine Chemicals accepts Vijay Anand resignation as director
- Vijay Anand resigns as independent director effective September 17, 2026
- Cites increased professional obligations and limited time for board duties
- Holds chairman roles across multiple committees at Pondy Oxides and Chemicals
- Also serves as chairman of audit and nomination committees at Sasmos HET Technologies
- Resignation filed under SEBI LODR Regulation 30 with no other material reasons cited

*this image is generated using AI for illustrative purposes only.
DCM Shriram Fine Chemicals accepted the resignation of Vijay Anand as an independent director effective September 17, 2026. The departure follows Anand’s citation of pressing professional commitments limiting his board availability.
The company disclosed the move under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. Anand confirmed in his resignation letter that no other material reasons influenced his decision to step down.
Director Profile and Other Roles
Anand continues to hold significant positions in other listed entities. His current directorships include:
- Pondy Oxides and Chemicals Limited: Chairman of the Audit Committee, Stakeholders’ Relationship Committee, Nomination and Remuneration Committee, Risk Management Committee, and Corporate Social Responsibility Committee.
- Sasmos HET Technologies Limited: Chairman of the Audit Committee and Nomination and Remuneration Committee.
Regulatory Compliance
The filing aligns with SEBI Master Circular No. HO/49/14/14(7)2025-CFD-POD2/I/3762/2026 dated January 30, 2026. Kokila Arora, Company Secretary and Compliance Officer, signed the intimation.
Historical Stock Returns for DCM Shriram Fine Chemicals
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| -2.99% | -4.80% | -1.07% | +12.07% | -47.41% | -47.41% |
Will DCM Shriram Fine Chemicals initiate a search for a new independent director immediately, and what is the expected timeline for board replenishment?
How might Vijay Anand's departure impact the composition and effectiveness of the Audit and Nomination committees at Pondy Oxides and Sasmos HET Technologies?
Are there any pending strategic decisions or regulatory filings at DCM Shriram that could be delayed or affected by this change in board leadership?


































